552
Participants
Start Date
April 30, 2011
Primary Completion Date
August 31, 2011
Study Completion Date
February 29, 2012
Formoterol/Budesonide
formoterol and budesonide will be administered at the 12/400 µg dosage, twice a da for 12 weeks.
Foraseq
foraseq will be administered at the 12/400 µg dosage, twice a da for 12 weeks.
Alenia
Alenia will be administered at the 12/400 µg dosage, twice a da for 12 weeks.
Centro de Referencia em Enfermidades Respiratoria e Alergica, Salvador
Hospital de Clinicas UFPR, Curitiba
IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada, São Paulo
Stelmach Pesquisa Clinica, São Paulo
Clinica de Alergia Martti Antila, Sorocaba
Lead Sponsor
Eurofarma Laboratorios S.A.
INDUSTRY